Weight-loss injections such as Mounjaro and Wegovy have changed the way obesity is treated. For many patients, they reduce appetite, improve control around food and support clinically meaningful weight loss.
However, one of the most common questions patients now ask is:
“Will I need to stay on Mounjaro or Wegovy for life?”
The answer is not the same for everyone. Some patients may benefit from longer-term treatment, while others may be able to reduce or stop medication with the right support. What is clear is that stopping treatment should not be treated as an afterthought. It needs to be planned carefully.
At Harley Street Obesity Clinic, we help patients understand the role of weight-loss injections within a long-term medical weight-management plan.
Why This Question Matters
Mounjaro and Wegovy are not simple short-term diet aids. They work by influencing appetite, satiety and metabolic regulation. When they are effective, patients often eat less, feel fuller sooner and experience fewer intrusive food thoughts.
This can make a significant difference. However, the biological drivers of obesity do not simply disappear once weight is lost. For patients, appetite signals return when medication is stopped.
Research on semaglutide, the active ingredient in Wegovy, found that after treatment withdrawal, participants regained a substantial proportion of the weight they had lost over the following year. Similar findings have been seen with tirzepatide, the active ingredient in Mounjaro, where stopping treatment led to substantial weight regain while continued treatment helped maintain and extend weight loss.
Does Stopping Always Mean Regaining All the Weight?
Generally but not always.
Some patients maintain part of their weight loss after stopping. However, research highlighted by the University of Cambridge suggests that people may regain around 60% of the weight they lost within 52 weeks of stopping weight-loss medication, with some weight loss still maintained longer term.
This means stopping treatment does not automatically mean returning to your starting weight. It does mean that the risk of regain is real and should be planned for.
Why Weight Regain Happens After Stopping
Weight regain after stopping Mounjaro or Wegovy is not usually due to lack of willpower. It reflects the way the body responds to weight loss.
Several factors are involved:
Appetite signals return
When the medication is stopped, hunger may increase. Cravings may return and portion control can become more difficult.
The body uses fewer calories
After weight loss, the body often requires fewer calories than before. This makes maintenance harder than losing weight in the first place.
Old habits can reappear
If eating patterns, activity levels and behavioural strategies have not been fully embedded during treatment, previous habits may gradually return. Its important to use the time to develop healthy eating habits which will make it easier when you stop the medication.
Obesity is a chronic condition
For most people, obesity behaves like a long-term relapsing medical condition. This means treatment may need to continue in some form, whether through medication, lifestyle support, surgery or a combination of approaches.
Do You Have to Stay on Mounjaro for Life?
Not necessarily, but most patients will need long-term treatment or may need to have regular short term courses..
In UK guidance, tirzepatide, sold as Mounjaro, is recognised as a treatment that may be used longer term in suitable patients. NHS England’s interim commissioning guidance notes that unlike some other NICE-recommended weight-management medicines, tirzepatide does not have a set maximum treatment period and may allow indefinite prescribing where appropriate. NICE also advises that patients should be told treatment could be long term and that stopping is likely to lead to weight regain without continued diet and activity changes.
For patients doing well on Mounjaro, the decision about duration depends on weight-loss response, side effects, medical history, cost, patient preference and long-term risk of regain.
Do You Have to Stay on Wegovy for Life?
Wegovy is slightly different in current UK guidance.
NICE recommends semaglutide, sold as Wegovy, as an option for weight management alongside a reduced-calorie diet and increased physical activity, but under NICE guidance it is used for a maximum of 2 years within a specialist weight-management service.
This does not mean every patient must stop all weight-management treatment after 2 years. It means there should be a planned review and a long-term strategy. This might include lifestyle maintenance, alternative medication, transition to another treatment or consideration of bariatric surgery where appropriate.
When Might Long-Term Treatment Be Appropriate?
Longer-term treatment may be considered when:
- Weight regain is likely without medication
- Obesity-related conditions such as type 2 diabetes, high blood pressure or sleep apnoea remain a concern
- The medication is well tolerated
- The patient continues to benefit clinically
- Lifestyle changes alone are unlikely to maintain results
Continued medication is not a failure. It is similar to long-term treatment for high blood pressure, diabetes or cholesterol, where ongoing therapy helps control a chronic medical condition.
When Might Stopping Be Appropriate?
Stopping or reducing medication may be appropriate if:
- Side effects are significant
- Weight loss has plateaued without further benefit
- The patient has reached a stable and healthy maintenance point
- A different treatment pathway is more suitable
- The patient prefers not to remain on medication long term
The key is that stopping should be planned, monitored and supported.
What Should a Maintenance Plan Include?
A maintenance plan should ideally begin before medication is reduced or stopped.
This may include:
- A structured nutrition plan
- Protein and fibre targets to support fullness
- Resistance exercise to protect muscle mass
- Regular weight and body composition monitoring
- Behavioural strategies for hunger, cravings and emotional eating
- A clear plan for what to do if weight starts to rise again
Without this structure, patients are more likely to regain weight and lose confidence.
Could Pills Replace Injections in the Future?
The future of obesity treatment is changing quickly. Recent reports have highlighted trial data for oral GLP-1 medicines that may help some patients maintain weight loss after coming off injections. These treatments are not yet a simple replacement for current care, but they suggest that future maintenance options may become more flexible.
For now, patients should make decisions based on current licensed treatments, medical supervision and individual risk assessment.
Safety Still Matters
Mounjaro and Wegovy can be highly effective, but they are still prescription medicines. The MHRA has reminded prescribers and patients that GLP-1 medicines are generally considered safe and effective for authorised uses but are not without risk. Patients should seek urgent medical advice if they experience symptoms suggestive of pancreatitis such as severe persistent abdominal pain, particularly if it radiates to the back and is associated with nausea or vomiting.
This is why ongoing clinical review is important, especially when changing dose, stopping treatment or switching approach.
How Harley Street Obesity Clinic Can Help
At Harley Street Obesity Clinic, we support patients through the full weight-management journey, not just the starting prescription.
Our approach includes:
- Medical assessment before treatment
- Careful selection of the most appropriate medication
- Monitoring of response, side effects and health markers
- Maintenance planning before medication is reduced or stopped
- Advice on alternative options including bariatric surgery where appropriate
We understand that the real goal is not simply losing weight. It is maintaining better health safely and sustainably.
Take the Next Step
You may not need to stay on Mounjaro or Wegovy for life, but you do need a long-term plan.
If you are currently using weight-loss injections, considering starting treatment or wondering whether it is safe to stop, specialist advice can help you make the right decision.